Method for providing hyaluronic acid

a technology of hyaluronic acid and hyaluronic acid, which is applied in the directions of enzymology, organic chemistry, transferases, etc., can solve the problems of insufficient major health and economic problems, and the inability to achieve de novo biosynthesis of ha, etc., to facilitate the separation of streptococcal infections and associated debris

Inactive Publication Date: 2001-08-21
THE BOARD OF RGT UNIV OF OKLAHOMA
View PDF10 Cites 70 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

A preferred technique for isolation of HA is described in U.S. Pat. No. 4,517,295 in which the organic carboxylic acid, trichloroacetic acid, is added to the bacterial suspension at the end of the fermentation. The trichloroacetic acid causes the bacterial cell to clump and die and facilitates the ease of separating these cells and associated debris from HA, the desired product. The clarified supernatant is concentrated and dialyzed to remove low molecular weight contaminants including the organic acid. The aforementioned procedure utilizes Millipore TM filtration through filter cassettes containing 0.22 mm pore size filters. Diafiltration is continued until the conductivity of the solution decreases to approximately 0.5 mega-ohms.

Problems solved by technology

The incidence of Streptococcal infections is a major health and economic problem worldwide, particularly in the developing countries (21).
This may be because in vitro systems developed to date are inadequate in that de novo biosynthesis of HA has not been accomplished.
Thus, totally ex vivo methods of producing HA have not been forthcoming.
It is generally felt that isolation of HA from rooster comb is laborious and difficult, since one starts with HA in a less pure state.
Unfortunately, very high molecular weight HA, such as that ranging up to 10.sup.7, has been difficult to obtain by currently available isolation procedures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for providing hyaluronic acid

Examples

Experimental program
Comparison scheme
Effect test

example i

ISOLATION OF THE .[.HYALURONATE SYNTHASE.]. .Iadd.RECOMBINANT DNA SEGMENT IDENTIFIED IN FIG. 5 .Iaddend.GENE FROM STREPTOCOCCUS EQUISIMILIS STRAIN D181

1. Isolation of genomic DNA from D181

Genomic DNA was isolated from S. equisimilis strain D181 and purified by CsCl-ethidium bromide density ultracentrifugation as follows.

Streprococcus equisimilis strain D181 was obtained in lyophilized form from the Rockefeller University Collection. The bacteria were grown in brain heart infusion (BHI) broth. Large scale isolation of genomic DNA from D181 was performed using a modification of the method of Wilson (33). Briefly, 100-ml culture of D181 was grown to saturation, the cells were pelleted for 10 min at 4,000.times.g in a Beckman JA-20 rotor and the supernatant discarded. The cell pellet was resuspended in 10 ml of 0.1M NaOAc, pH 5, 0.15M NaCl containing 10 mg testicular hyaluronidase (Sigma) and incubated at 37.degree. C. for 1 hr. The bacteria were pelleted, resuspended in 10 ml of TE buf...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to view more

Abstract

Disclosed are DNA segments encoding <DEL-S DATE="20010821" ID="DEL-S-00001">hyaluronic acid synthase which are employed to construct recombinant cells useful in the production of hyaluronate synthase or hyaluronic acid (HA)<DEL-E ID="DEL-S-00001"> <INS-S DATE="20010821" ID="INS-S-00001">the recombinant DNA segment identified in FIG. 5. <INS-E ID="INS-S-00001">In preferred aspects, chromosomal DNA from Streptococcus equisimilis is partially digested with EcoRI and the resultant fragments are ligated to form recombinant vectors. These vectors are useful in the transformation of host cells such as E. coli and or Streptococcal hosts. <DEL-S DATE="20010821" ID="DEL-S-00002">Resultant transformants are screened by the novel screening assays to identify colonies which have incorporated HA synthase DNA in a form that is being actively transcribed into the corresponding HA synthase enzyme. These colonies may be selected and employed in the production of the enzyme itself or its product, HA.<DEL-E ID="DEL-S-00002"> <INS-S DATE="20010821" ID="INS-S-00002">The recombinant DNA segment identified in FIG. 5 is then inserted into a recombinant Streptococcal host for the production of hyaluronic acid (HA).<INS-E ID="INS-S-00002">

Description

BACKGROUND OF THE INVENTION1. Field of the InventionThe present invention relates to .[.DNA encoding the enzyme hyaluronate synthase, and to the use of this DNA in the preparation of recombinant cells for the production of the hyaluronate synthase enzyme and / or hyaluronic acid.]. .Iadd.a method for providing hyaluronic acid..Iaddend.2. Description of the Related ArtThe incidence of Streptococcal infections is a major health and economic problem worldwide, particularly in the developing countries (21). One reason for this is due to the ability of Streptococcal bacteria to often grow undetected by the body's phagocytic cells (i.e., macrophages and polymorphonuclear cells (PMNs). These cells are responsible for recognizing and engulfing foreign microorganisms. One effective way by which the bacteria evade surveillance is by coating themselves with polysaccharide capsules, such as hyaluronic acid (HA) capsules. Since polysaccharides are generally nonimmunogenic, the encapsulated bacteri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(United States)
IPC IPC(8): C12P19/26C12P19/00C12N15/52C12N9/10C12N1/21
CPCC12N9/10C12N9/1051C12N15/52C12P19/26Y10S435/849Y10S435/885
Inventor WEIGEL, PAUL H.PAPACONSTANTINOU, JOHN
Owner THE BOARD OF RGT UNIV OF OKLAHOMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products